STOCK TITAN

BYND Cannasoft Enterprises Inc. - BCAN STOCK NEWS

Welcome to our dedicated page for BYND Cannasoft Enterprises news (Ticker: BCAN), a resource for investors and traders seeking the latest updates and insights on BYND Cannasoft Enterprises stock.

BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) is an Israeli-based company dedicated to developing innovative solutions in the CRM and medical cannabis sectors. The company is renowned for its proprietary Benefit CRM, which helps small and medium-sized businesses streamline their daily operations, including sales, personnel, marketing, call center activities, and asset management.

Building on its two decades of experience in CRM software, BYND Cannasoft is currently developing a groundbreaking Cannabis CRM Platform designed to enhance the medical cannabis industry's organization, accessibility, and transparency. This platform will feature a comprehensive Job Management (BENEFIT) and a modular system (CANNASOFT) for effectively managing farms and greenhouses.

One of the company's most notable achievements is the development of the EZ-G device, a therapeutic apparatus that employs proprietary software to regulate the flow of CBD oil, hemp seed oil, and other natural oils into female reproductive tissues. This AI-based device offers technological advancements as a sex toy, providing a more realistic experience. The EZ-G device includes sensors that measure pressure, temperature, conductivity, and heart rate, enabling a customized user experience controlled via a Bluetooth app on a smartphone.

The company has recently celebrated several milestones, including the successful completion of the laboratory testing phase for the EZ-G device and the filing of multiple patents to secure intellectual property rights. Additionally, BYND Cannasoft has significantly expanded its global presence, closing an underwritten public offering that raised approximately $2.6 million, and it has received a license from the Israeli Ministry of Health to engage in the medical cannabis market.

Under the leadership of CEO and Director Yftah Ben Yaackov, BYND Cannasoft is poised to make significant strides in women's health and medical cannabis research while driving sustainability and innovation. The company continues to form strategic partnerships and collaborations to advance its mission and deliver cutting-edge solutions to consumers worldwide.

For further information, please visit the company’s website at www.cannasoft-crm.com, the CSE’s website at www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc, and on SEDAR at www.sedar.com.

Rhea-AI Summary
Aegis Capital Corp. served as the Sole Bookrunner for BYND Cannasoft Enterprises Inc.'s $7.0 Million Underwritten Public Offering on NASDAQ:BCAN.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.31%
Tags
-
Rhea-AI Summary
BYND Cannasoft Enterprises Inc. announced that its EZ-G project team has arrived in Shenzhen, China to sign agreements with two of the largest manufacturers in the province to begin production of the EZ-G device and EZ-G Capsules. The company intends to start mass production after the Chinese New Year and aims to start selling the EZ-G device and capsules in the second quarter of 2024. The positive response from potential customers reflects the demand for the innovative EZ-G device and capsules, highlighting the company's commitment to delivering its technology to customers. CEO Yftah Ben Yaackov expressed confidence in bringing a high-level technological product to the market and generating significant sales and profits.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
none
-
Rhea-AI Summary
Aegis Capital Corp. facilitated a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.53%
Tags
Rhea-AI Summary
BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) has expanded its intellectual property portfolio for its EZ-G Device by filing a national phase application for its EZ-G Device in 11 jurisdictions, including the U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
none
-
Rhea-AI Summary
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) has submitted a research and development plan to develop CRM software combined with AI for the medical cannabis industry, with a planned budget of US$1.5 million. The Israel Innovation Authority's Fast-Track Fund has been increased to US$100 million to support the high-tech sector amid wartime challenges. The Finance Ministry's commitment to increasing support for the high-tech sector underscores the government's dedication to sustaining the industry during this challenging period and ensuring its continued growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.36%
Tags
none
-
Rhea-AI Summary
BYND Cannasoft Enterprises Inc. refocuses on its proprietary CRM platform to meet the increased demand for medical cannabis in Israel following recent regulatory reforms. The surge in licensed medical cannabis patients and the increase in post-trauma cases have led to a notable demand for cannabis products, prompting the company to concentrate on innovative elements in the field of artificial intelligence for data collection and analysis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.62%
Tags
none
Rhea-AI Summary
BCAN - BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) Reports Q2 2023 Financial Results, Revenue Up 21%. Net Loss Increases 242%. CEO Emphasizes Focus on Long-Term Growth and Product Development
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.2%
Tags
-
Rhea-AI Summary
BYND Cannasoft announces progress in developing AI-based smart treatment devices for sexual wellness market, including EZ-G device for women and men. Prototype equipped with sensors to enhance user pleasure. Company secures multiple patents to protect IP. Completion of laboratory testing phase for EZ-G device. Successfully closed underwritten public offering, raising $2.6 million. Received license to engage in medical cannabis market in Israel. Aims to capture 3% market share, worth $15 million in sales within a year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.27%
Tags
none

FAQ

What is BYND Cannasoft Enterprises Inc.?

BYND Cannasoft Enterprises Inc. is an Israeli-based company specializing in CRM software and medical cannabis solutions.

What products does the company offer?

The company offers Benefit CRM software for small and medium-sized businesses and is developing a Cannabis CRM Platform and the EZ-G device for women's health.

What is the EZ-G device?

The EZ-G device is an AI-based therapeutic device that regulates the flow of CBD oil into female reproductive tissues, offering both medical and recreational benefits.

Where is BYND Cannasoft Enterprises Inc. located?

The company is based in Israel and all of its business operations and revenues are currently generated there.

What recent financial milestones has the company achieved?

BYND Cannasoft recently closed an underwritten public offering, raising approximately $2.6 million to fund product development, sales, and marketing.

What are the company’s plans for global expansion?

The company is working to establish a strong international presence, forming strategic partnerships, and securing intellectual property rights in multiple jurisdictions.

What licenses has BYND Cannasoft recently obtained?

The company has received a license from the Israeli Ministry of Health to engage in medical cannabis trading without direct contact with the substance.

How does the Benefit CRM software benefit businesses?

Benefit CRM helps small and medium-sized businesses optimize daily operations, including sales, personnel, marketing, call center activities, and asset management.

Who is the CEO of BYND Cannasoft Enterprises Inc.?

Yftah Ben Yaackov is the CEO and Director of BYND Cannasoft Enterprises Inc.

How can I get more information about the company?

For more information, visit the company’s website at www.cannasoft-crm.com or refer to their profiles on the CSE and SEDAR websites.

BYND Cannasoft Enterprises Inc.

Nasdaq:BCAN

BCAN Rankings

BCAN Stock Data

6.37M
7.77M
28.28%
1.46%
5.71%
Water and Sewer Line and Related Structures Construction
Construction
Link
United States of America
Kiryat Motzkin